Effects of a new injectable short-term release deslorelin in foal-heat mares.
Abstract: Mares treated with subcutaneous deslorelin implants on the first postpartum estrus early in the breeding season had significant reductions in the number of large follicles at early pregnancy examinations and delayed return to estrus (in mares that failed to become pregnant); these adverse effects were attributed to a prolonged release of the drug from the implant. In 2003, an injectable short-term release (<24 h) deslorelin product became available. The objective of this study was to determine if this product would hasten ovulation in early foaling first postpartum estrus mares without reducing the number of large follicles at early pregnancy examination (14-15 days postovulation). Beginning 5-6 days postpartum, first postpartum estrus (foal-heat) mares were teased daily and examined thrice weekly (Tuesday, Thursday and Saturday) by transrectal ultrasonography. Mares in estrus with a follicle > or = 34 mm diameter on Tuesdays or Thursdays were alternately assigned to: Treatment 1, n = 17; 1.5 mg injectable short-term release deslorelin, or Treatment 2, n = 16; Control (no treatment). The schedule allowed accurate determination of the number of mares ovulating within 2 days of treatment (i.e., ovulations detected on Thursday or Saturday). Mares were mated on the day of treatment and at 2-day intervals until either ovulation was confirmed or until behavioral estrus ceased. Transrectal ultrasonography was done 14-15 days after ovulation to assess ovarian follicles and pregnancy status. Fewer covers were required and more mares ovulated within 2 days of treatment in deslorelin-treated versus Control mares (P < 0.01). Pregnancy rates were normal (69%) in deslorelin-treated mares. The number of large follicles 14-15 days after ovulation did not differ between deslorelin-treated and Control mares (P > 0.10), suggesting follicular suppression did not occur with this formulation of deslorelin.
Publication Date: 2004-07-15 PubMed ID: 15251234DOI: 10.1016/j.theriogenology.2003.12.004Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Comparative Study
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research paper investigates the impacts of a new deslorelin product on foal-heat mares, particularly with regards to hastening ovulation and preserving the number of large follicles. The findings demonstrated that the product was successful in these objectives, reducing the need for covers, increasing instances of ovulation within 2 days of treatment, and maintaining normal pregnancy rates without leading to follicular suppression.
Research Objective
- The main objective of this research was to assess the effectiveness of a new injectable short-term release deslorelin product on early foaling first postpartum (after birth) estrus mares (mares in heat following foaling), with a specific focus on whether the product would accelerate ovulation whilst maintaining the number of large ovarian follicles at early pregnancy examinations.
Methodology
- From approximately 5-6 days after birth, first postpartum estrus mares were tested daily and examined three times a week via transrectal ultrasonography.
- Estrus mares with a follicle of 34 mm or larger in diameter were randomly given one of two treatments: 1.5 mg of injectable deslorelin, or no treatment (control).
- The testing schedule was designed to accurately determine the number of mares that ovulated within 2 days of treatment.
- Once ovulation had been confirmed or estrus behavior had ceased, mares were mated every two days.
- Pregnancy status and ovarian follicles were assessed 14-15 days after ovulation using transrectal ultrasonography.
Findings
- The deslorelin treatment was shown to be effective, as fewer matings were required and a higher number of mares ovulated within 2 days of treatment compared to the control group.
- The pregnancy rates in the deslorelin-treated mares remained normal, at 69%.
- No significant difference was seen in the number of large follicles 14-15 days after ovulation between the control and treated groups, suggesting this formulation of deslorelin did not result in follicular suppression.
Cite This Article
APA
Stich KL, Wendt KM, Blanchard TL, Brinsko SP.
(2004).
Effects of a new injectable short-term release deslorelin in foal-heat mares.
Theriogenology, 62(5), 831-836.
https://doi.org/10.1016/j.theriogenology.2003.12.004 Publication
Researcher Affiliations
- Department of Large Animal Medicine and Surgery, College of Veterinary Medicine, Texas A&M University, College Station 77843-4475, USA.
MeSH Terms
- Animals
- Breeding
- Drug Implants
- Estrus / drug effects
- Female
- Horses / physiology
- Injections
- Ovarian Follicle / anatomy & histology
- Ovarian Follicle / drug effects
- Ovulation Induction / veterinary
- Postpartum Period
- Pregnancy
- Triptorelin Pamoate / administration & dosage
- Triptorelin Pamoate / adverse effects
- Triptorelin Pamoate / analogs & derivatives
- Ultrasonography / veterinary
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists